[HTML][HTML] Chronic heart failure
…, P Prien, S Störk, NCPG on Chronic… - Deutsches Ärzteblatt …, 2018 - ncbi.nlm.nih.gov
… -valsartan, licensed for the treatment of heart failure in 2015, … In the pivotal trial, the
sacubitril-valsartan group showed a 4.7… causes or hospitalization for heart failure—after a median …
sacubitril-valsartan group showed a 4.7… causes or hospitalization for heart failure—after a median …
Tolerability of sacubitril/valsartan in patients with advanced heart failure: analysis of the LIFE trial run-in
JM Vader, MM Givertz, RC Starling, SE McNulty… - Heart Failure, 2022 - jacc.org
… Heart Failure) trial showed that sacubitril/valsartan reduced the relative risk of cardiovascular
mortality and heart failure … period during which sacubitril/valsartan was uptitrated to a target …
mortality and heart failure … period during which sacubitril/valsartan was uptitrated to a target …
… of sacubitril/valsartan in the PARADIGM-HF trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) …
N Okumura, PS Jhund, J Gong… - … : Heart Failure, 2016 - Am Heart Assoc
… /valsartan with enalapril in patients with chronic heart failure with reduced EF. Eligibility
requirements at screening included an age of at least 18 years, New York Heart Association …
requirements at screening included an age of at least 18 years, New York Heart Association …
Real-life indications to sacubitril/valsartan treatment in patients with chronic systolic heart failure
… the introduction of sacubitril/valsartan (Entresto) in patients with heart failure (HF) and … -life
eligibility for sacubitril/valsartan in a population of patients suffering from chronic HF, regularly …
eligibility for sacubitril/valsartan in a population of patients suffering from chronic HF, regularly …
Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure
IS Anand, A Deswal, DJ Kereiakes… - Vascular health and …, 2010 - Taylor & Francis
… qd use of valsartan in hypertension, no clinical studies have compared the tolerability of
this strategy with bid dosing in heart failure; however, 2 trials using valsartan 160 mg qd have …
this strategy with bid dosing in heart failure; however, 2 trials using valsartan 160 mg qd have …
Sacubitril-valsartan for the treatment of heart failure: effectiveness and value
DA Ollendorf, AT Sandhu, SD Pearson - JAMA internal medicine, 2016 - jamanetwork.com
… of heart failure in the United States: a policy statement from the American Heart Association.
… Forecasting the impact of heart failure in the United States: a policy statement from the …
… Forecasting the impact of heart failure in the United States: a policy statement from the …
… cardiac death in patients with chronic heart failure with reduced left ventricular ejection fraction. Expert opinion of the Heart Rhythm and Heart Failure Sections of the …
M Grabowski, K Ozierański, P Balsam… - Polish Heart …, 2019 - journals.viamedica.pl
… AbstrAct Exacerbation of chronic heart failure (HF) is the most common cause of … / valsartan,
a drug belonging to angiotensin receptor–neprilysin inhibitors (ARNIs). Sacubitril / valsartan …
a drug belonging to angiotensin receptor–neprilysin inhibitors (ARNIs). Sacubitril / valsartan …
Sacubitril/valsartan in heart failure and end‐stage renal insufficiency
A Heyse, L Manhaeghe, E Mahieu… - … heart failure, 2019 - Wiley Online Library
… /valsartan in a patient treated with hemodialysis. We describe the case of a 67-year-old
man with heart failure with reduced ejection fraction due to an ischemic cardiomyopathy and …
man with heart failure with reduced ejection fraction due to an ischemic cardiomyopathy and …
Effect of sacubitril valsartan on cardiac function and endothelial function in patients with chronic heart failure with reduced ejection fraction
BH Li, KF Fang, PH Lin, YH Zhang… - Clinical …, 2021 - content.iospress.com
… chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic
heart failure … Developed with the special contribution of the Heart Failure Association (HFA) of …
heart failure … Developed with the special contribution of the Heart Failure Association (HFA) of …
Efficacy and safety of sacubitril‐valsartan in heart failure: a meta‐analysis of randomized controlled trials
H Zhang, T Huang, W Shen, X Xu, P Yang… - … Heart Failure, 2020 - Wiley Online Library
… Sacubitril-valsartan has been shown to have superior effects over angiotensin-converting …
with heart failure (HF) and hypertension. The efficacy and safety of sacubitril-valsartan in …
with heart failure (HF) and hypertension. The efficacy and safety of sacubitril-valsartan in …